Financials
Financial year 2026
Anglopharma from De Panne, company number BE0406061794, closed financial year 2026 with a result of € 15,526 after tax. For that financial year Anglopharma recorded a gross margin of € 176,237 and equity of € 504,483. Compared with financial year 2025, the result moved from € -83,090 to € 15,526. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
€ 504,483
▼ 1% vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 15,526
▲ still € 83,090 loss in 2025
Profit after tax over the fiscal year.
€ 223,629
▲ 7% vs 2025
Cash and bank balances on the last day of the fiscal year.
€ 21,935 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2026
1.4
Average over the fiscal year, from the social balance sheet.
€ 133,694
▲ 1% vs 2025
€ 95,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 5,858
▲ 200% vs 2025
Book value of vehicles, furniture and equipment.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
€ 91,506
▲ 28% vs 2025
Supplier invoices still open on the last day of the fiscal year.
€ 35,687
▲ 51% vs 2025
Taxes, VAT and social contributions still to pay.
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 157,562 | € 224,380 | € 204,937 | € 176,237 | ▼ 14% |
| Profit after taxes | € 38,169 | € 65,733 | € -83,090 | € 15,526 | ▲ € 98,616 |
| Equity | € 528,248 | € 593,981 | € 510,891 | € 504,483 | ▼ 1% |
| Total debts | € 209,930 | € 148,056 | € 133,113 | € 165,334 | ▲ 24% |
| Cash | € 53,842 | € 72,765 | € 208,153 | € 223,629 | ▲ 7% |
| Land & buildings | - | - | € 99,578 | € 97,828 | ▼ 2% |
| Retained profit | € 508,240 | € 573,974 | € 490,884 | € 484,475 | ▼ 1% |
| Dividend | € 0 | € 0 | € 0 | € 21,935 | |
| Balance sheet total | € 738,177 | € 742,037 | € 644,004 | € 669,817 | ▲ 4% |
| Employees (FTE) | 1.4 | 1.4 | 1.4 | 1.4 |
Key figures of Anglopharma, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 31 August 2027.
What happened to Anglopharma?
What happened at Anglopharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 15,526. Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in De Panne. KBO
In short
From € 38,169 profit in 2023 to € 15,526 profit in 2026.
Paid € 57,586 in corporate taxes since 2023.
Best year ever: 2024, with € 65,733 profit.
On average € 125,900 of value added per employee in 2026.
Management
Behind Anglopharma is Kris Trypsteen.
Directors
According to the 2026 annual accounts
Kris Trypsteen
Director
Establishments
Establishment units
Physical locations of this company
Zeelaan 126
8660 De Panne
Zeelaan 126A
8660 De Panne
Active since 1 September 1965
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0406.061.794
- VAT number
- BE 0406.061.794
- Registered office
- Zeelaan 126, 8660 De Panne
- Names & denominations
- Anglopharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 1 January 1968
- Peppol
- Active · Active since 23 Oct 2025
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten
Detailhandel in cosmetica en toiletartikelen